ES2126265T3 - Tableta de accion retardada con un cierto contenido de diclorofenaco de sodio. - Google Patents

Tableta de accion retardada con un cierto contenido de diclorofenaco de sodio.

Info

Publication number
ES2126265T3
ES2126265T3 ES95913097T ES95913097T ES2126265T3 ES 2126265 T3 ES2126265 T3 ES 2126265T3 ES 95913097 T ES95913097 T ES 95913097T ES 95913097 T ES95913097 T ES 95913097T ES 2126265 T3 ES2126265 T3 ES 2126265T3
Authority
ES
Spain
Prior art keywords
certain content
pct
delayed action
action tablet
sodium dichlorophene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95913097T
Other languages
English (en)
Other versions
ES2126265T5 (es
Inventor
Wilfried Fischer
Karin Klokkers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6512563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2126265(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hexal AG filed Critical Hexal AG
Publication of ES2126265T3 publication Critical patent/ES2126265T3/es
Application granted granted Critical
Publication of ES2126265T5 publication Critical patent/ES2126265T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION TRATA DE UNA TABLETA DE LIBERACION RETARDADA CONTENIENDO DICLOFENAC-NA COMO PRINCIPIO ACTIVO Y METILHIDROXIPROPIL-CELULOSA COMO AGENTE RETARDANTE.
ES95913097T 1994-03-11 1995-03-13 Tableta de accion retardada con un cierto contenido de diclofenaco de sodio. Expired - Lifetime ES2126265T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4408326 1994-03-11
DE4408326A DE4408326A1 (de) 1994-03-11 1994-03-11 Retardtablette mit einem Gehalt an Diclofenac-Na

Publications (2)

Publication Number Publication Date
ES2126265T3 true ES2126265T3 (es) 1999-03-16
ES2126265T5 ES2126265T5 (es) 2004-10-16

Family

ID=6512563

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95913097T Expired - Lifetime ES2126265T5 (es) 1994-03-11 1995-03-13 Tableta de accion retardada con un cierto contenido de diclofenaco de sodio.

Country Status (14)

Country Link
US (1) US5874107A (es)
EP (1) EP0749304B9 (es)
JP (1) JPH09509953A (es)
AT (1) ATE173399T1 (es)
AU (1) AU692534B2 (es)
CA (1) CA2185242C (es)
DE (2) DE4408326A1 (es)
DK (1) DK0749304T4 (es)
ES (1) ES2126265T5 (es)
FI (1) FI118294B (es)
GR (1) GR3029278T3 (es)
NO (1) NO317396B1 (es)
PL (1) PL177607B1 (es)
WO (1) WO1995024188A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
AU3860797A (en) * 1997-07-16 1999-02-10 Antrin Research Limited Pharmaceutical formulations for oral administration
JP4565456B2 (ja) * 1999-11-02 2010-10-20 塩野義製薬株式会社 着色顆粒の色素定着法
DE10029201A1 (de) 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
MXPA05008033A (es) * 2003-01-28 2006-04-28 Collegium Pharmaceutical Inc Composiciones de milnacipran en forma de multiparticulas para administracion oral.
US8107531B2 (en) * 2003-09-07 2012-01-31 Microsoft Corporation Signaling and repeat padding for skip frames

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786503A (en) † 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US5236713A (en) * 1987-10-21 1993-08-17 Teikoku Seiyaku Kabushiki Kaisha Preparation for intermittently releasing active agent applicable to oral cavity
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata

Also Published As

Publication number Publication date
CA2185242A1 (en) 1995-09-14
DK0749304T4 (da) 2004-03-29
GR3029278T3 (en) 1999-05-28
CA2185242C (en) 2004-11-23
FI963567A0 (fi) 1996-09-10
DE59504270D1 (de) 1998-12-24
PL316196A1 (en) 1996-12-23
NO317396B1 (no) 2004-10-25
US5874107A (en) 1999-02-23
FI118294B (fi) 2007-09-28
JPH09509953A (ja) 1997-10-07
PL177607B1 (pl) 1999-12-31
EP0749304B9 (de) 2006-03-08
AU2069595A (en) 1995-09-25
ATE173399T1 (de) 1998-12-15
EP0749304B1 (de) 1998-11-18
DE4408326A1 (de) 1995-09-14
NO963796L (no) 1996-11-06
FI963567A (fi) 1996-09-10
NO963796D0 (no) 1996-09-10
AU692534B2 (en) 1998-06-11
EP0749304B2 (de) 2004-03-03
ES2126265T5 (es) 2004-10-16
DK0749304T3 (da) 1999-08-02
EP0749304A1 (de) 1996-12-27
WO1995024188A1 (de) 1995-09-14

Similar Documents

Publication Publication Date Title
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
HUT73807A (en) 5-ht1-like indole derivatives and pharmaceutical compositions containing them
ZA962242B (en) Storage-stable drug forms.
DK0833611T3 (da) Sammensætning omfattende et aktivt middel opløst i en glasdannende bærer og fremgangsmåde til fremstilling heraf
HU76547A2 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
BR9509019B1 (pt) comprimido isento de solventes orgÂnicos.
IL117531A (en) Transparent rapid release compositions of non-steroidal analgesics
ES2126265T3 (es) Tableta de accion retardada con un cierto contenido de diclorofenaco de sodio.
HK1050707A1 (zh) 使用蘇力菌毒素實現對大齒猛蟻(螞蟻)的控制
PT749308E (pt) Pastilha, revestida com filme, de paracetamol e domperidona
SE9401540D0 (sv) Munhygienkomposition
TW284777B (es)
HU9500197D0 (en) Gross-linked polyhydroxylic material for enzymatically controlled drug release
DE69418035T2 (de) Hiv-proteaseinhibitoren
HUT77868A (hu) Imidazopiridin-azolidinonok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
PL320198A1 (en) Children-safe active substance plaster package
ES2134941T3 (es) Pastillas de lactulosa.
DE69619543D1 (de) Carbonyleisen-tablette durch direktverpressung
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 749304

Country of ref document: ES